Cleared Traditional

K896174 - PROTEIN S ANTIGEN ROCKET EID KIT

K896174 is the FDA 510(k) clearance for PROTEIN S ANTIGEN ROCKET EID KIT by Helena Laboratories. It is a Class 2 Hematology device (product code GGP) cleared through the Traditional 510(k) pathway after a 141-day FDA review.

K896174 · Helena Laboratories · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1990
Decision
141d
Days
Class 2
Risk

K896174 is an FDA 510(k) clearance for the PROTEIN S ANTIGEN ROCKET EID KIT, CAT. NO. 5359. Classified as Test, Qualitative And Quantitative Factor Deficiency (product code GGP), Class II - Special Controls.

Submitted by Helena Laboratories (Beaumont, US). The FDA issued a Cleared decision on March 15, 1990 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7290 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Helena Laboratories devices

Submission Details

510(k) Number K896174 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 1989
Decision Date March 15, 1990
Days to Decision 141 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 113d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GGP Test, Qualitative And Quantitative Factor Deficiency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGP Test, Qualitative And Quantitative Factor Deficiency

All 126
Devices cleared under the same product code (GGP) and FDA review panel - the closest regulatory comparables to K896174.
LIATEST PROTEIN S KIT
K912468 · American Bioproducts Co. · Oct 1991
DADE PROTEIN C CLOTTING ASSAY
K903468 · Baxter Healthcare Corp · Feb 1991
FREE PROTEIN S REAGENT CAT. NO. 5363
K904247 · Helena Laboratories · Jan 1991
ORTHOKROME* FACTOR VIII
K900395 · Ortho Diagnostic Systems, Inc. · Mar 1990
ORTHOKROME* ANTIPLASMIN
K900397 · Ortho Diagnostic Systems, Inc. · Mar 1990
ORTHOKROME* PROTEIN C
K900398 · Ortho Diagnostic Systems, Inc. · Mar 1990